ORIC Pharmaceuticals Stock Forecast

Stock Price Forecast

The 11 analysts that cover ORIC Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $20, which forecasts a 45.77% increase in the stock price over the next year. The lowest target is $15 and the highest is $25.

Price Target: $20 (+45.77%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$15	$20	$20	$25
Change	+9.33%	+45.77%	+45.77%	+82.22%

Analyst Ratings

The average analyst rating for ORIC Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26
Strong Buy	6	6	5	5	5	5
Buy	4	4	5	6	7	7
Hold	0	0	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	10	11	12	13	13

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Yigal Nochomovitz Citigroup	Citigroup	Strong Buy Maintains $16 → $17	Strong Buy	Maintains	$16 → $17	+23.91%	Feb 24, 2026
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $23 → $25	Strong Buy	Maintains	$23 → $25	+82.22%	Feb 24, 2026
David Nierengarten Wedbush	Wedbush	Buy Reiterates $20	Buy	Reiterates	$20	+45.77%	Feb 24, 2026
David Nierengarten Wedbush	Wedbush	Buy Reiterates $20	Buy	Reiterates	$20	+45.77%	Jan 13, 2026
Kelsey Goodwin Piper Sandler	Piper Sandler	Buy Initiates $22	Buy	Initiates	$22	+60.35%	Jan 7, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

1.75M

EPS This Year

-1.45

from -1.47

EPS Next Year

-1.60

from -1.45

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	-	-	-	-	1.75M
Revenue Growth	-	-	-	-	-	-	-
EPS	-2.07	-2.25	-1.96	-1.83	-1.47	-1.45	-1.60
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	18	14

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	16.3M
Avg	n/a	1.8M
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-1.22	-1.25
Avg	-1.45	-1.60
Low	-1.72	-1.84

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.